Center-Authored Papers

Filters: Author is Eldar-Lissai, Adi  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Time Factors
Survival Analysis
Recombinant Proteins
Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.  2008.  Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
Randomized Controlled Trials as Topic
Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.  2008.  Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
Quality-Adjusted Life Years
Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.  2008.  Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
Patient Discharge
NEUTROPENIA
Monte Carlo Method
Models, Economic
Middle Aged
Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.  2008.  Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
Meta-Analysis as Topic
Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.  2008.  Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
Length of Stay
Humans
Hospitalization
Hospital Mortality
Hematopoietic Cell Growth Factors
Hematopoiesis
Granulocyte Colony-Stimulating Factor
Fever